Novo Nordisk
NVO
#28
Rank
C$505.66 B
Marketcap
$116.10
Share price
2.97%
Change (1 day)
-18.06%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): C$24.09 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$39.69 Billion. In 2023 the company made an earning of C$22.10 Billion, an increase over its 2022 earnings that were of C$14.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$24.09 B9.01%
2023 C$22.10 B57.64%
2022 C$14.02 B5.35%
2021 C$13.31 B12.47%
2020 C$11.83 B13.07%
2019 C$10.46 B-3.35%
2018 C$10.83 B1.79%
2017 C$10.63 B4.52%
2016 C$10.17 B9.42%
2015 C$9.30 B8.24%
2014 C$8.59 B3.45%
2013 C$8.30 B19.02%
2012 C$6.98 B15.21%
2011 C$6.05 B17.71%
2010 C$5.14 B24.78%
2009 C$4.12 B10.62%
2008 C$3.72 B55.97%
2007 C$2.39 B7.07%
2006 C$2.23 B18.18%
2005 C$1.88 B11.33%
2004 C$1.69 B
2002 C$1.03 B-14.39%
2001 C$1.21 B-52.82%
2000 C$2.56 B250%
1999 C$0.73 B31.21%
1998 C$0.55 B34.31%
1997 C$0.41 B11.46%
1996 C$0.37 B9.03%
1995 C$0.34 B-3.15%
1994 C$0.35 B-0.67%
1993 C$0.35 B45.38%
1992 C$0.24 B-13.81%
1991 C$0.28 B37.12%
1990 C$0.20 B-0.79%
1989 C$0.20 B26.2%
1988 C$0.16 B24.97%
1987 C$0.13 B-0.9%
1986 C$0.13 B-7.78%
1985 C$0.14 B24.87%
1984 C$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.94 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.54 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.86 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.61 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France